Caroline Barton

699 total citations
9 papers, 501 citations indexed

About

Caroline Barton is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Caroline Barton has authored 9 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Caroline Barton's work include RNA modifications and cancer (3 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related molecular mechanisms research (3 papers). Caroline Barton is often cited by papers focused on RNA modifications and cancer (3 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related molecular mechanisms research (3 papers). Caroline Barton collaborates with scholars based in Australia, United Kingdom and Switzerland. Caroline Barton's co-authors include Susan J. Clark, Neville F. Hacker, Philippa M. O’Brien, Frances R. Balkwill, Frances Burke, John Smyth, Lucy Wall, Brian Gloss, Robert L. Sutherland and Aaron L. Statham and has published in prestigious journals such as Biochemical Journal, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

Caroline Barton

8 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caroline Barton Australia 8 362 175 123 83 72 9 501
Ali Özeş United States 10 620 1.7× 359 2.1× 148 1.2× 45 0.5× 44 0.6× 16 720
Xupeng Yue China 13 333 0.9× 214 1.2× 96 0.8× 24 0.3× 78 1.1× 16 532
Jinsong Liu United States 7 199 0.5× 105 0.6× 127 1.0× 56 0.7× 44 0.6× 16 386
Sumeet U. Nayak United States 9 422 1.2× 75 0.4× 223 1.8× 60 0.7× 87 1.2× 12 547
Olga Vaksman Israel 8 338 0.9× 252 1.4× 84 0.7× 33 0.4× 48 0.7× 8 426
Wei-Chao Hao China 9 216 0.6× 156 0.9× 74 0.6× 26 0.3× 74 1.0× 12 348
Rosario I. Corona United States 12 281 0.8× 120 0.7× 26 0.2× 99 1.2× 37 0.5× 20 387
Dongxue Su China 9 570 1.6× 112 0.6× 216 1.8× 34 0.4× 53 0.7× 12 691
Elisabeth Emilsen Norway 10 280 0.8× 80 0.5× 167 1.4× 23 0.3× 60 0.8× 17 428
Terry Hurst Australia 11 276 0.8× 63 0.4× 157 1.3× 202 2.4× 54 0.8× 18 477

Countries citing papers authored by Caroline Barton

Since Specialization
Citations

This map shows the geographic impact of Caroline Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Barton more than expected).

Fields of papers citing papers by Caroline Barton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Barton. The network helps show where Caroline Barton may publish in the future.

Co-authorship network of co-authors of Caroline Barton

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Barton. A scholar is included among the top collaborators of Caroline Barton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Barton. Caroline Barton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Kjær, Susanne K., Mark Linch, Andrew G. Purkiss, et al.. (2013). Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes. Biochemical Journal. 451(2). 329–342. 48 indexed citations
3.
Montavon, Céline, Brian Gloss, Kristina Warton, et al.. (2011). Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer. Gynecologic Oncology. 124(3). 582–588. 86 indexed citations
4.
Gloss, Brian, Kate Patterson, Caroline Barton, et al.. (2011). Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers. Cancer Letters. 318(1). 76–85. 43 indexed citations
5.
Barton, Caroline, Brian Gloss, Aaron L. Statham, et al.. (2009). Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival. British Journal of Cancer. 102(1). 87–96. 37 indexed citations
6.
Barton, Caroline, Susan J. Clark, Neville F. Hacker, & Philippa M. O’Brien. (2008). Epigenetic Markers of Ovarian Cancer. Advances in experimental medicine and biology. 622. 35–51. 13 indexed citations
7.
Barton, Caroline, Neville F. Hacker, Susan J. Clark, & Philippa M. O’Brien. (2008). DNA methylation changes in ovarian cancer: Implications for early diagnosis, prognosis and treatment. Gynecologic Oncology. 109(1). 129–139. 155 indexed citations
8.
Barton, Caroline, Derek Davies, Frances R. Balkwill, & Frances Burke. (2005). Involvement of both intrinsic and extrinsic pathways in IFN-γ-induced apoptosis that are enhanced with cisplatin. European Journal of Cancer. 41(10). 1474–1486. 34 indexed citations
9.
Wall, Lucy, Frances Burke, Caroline Barton, John Smyth, & Frances R. Balkwill. (2003). IFN-gamma induces apoptosis in ovarian cancer cells in vivo and in vitro.. PubMed. 9(7). 2487–96. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026